Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients

Abstract Neoplasm development in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) has been widely discussed. The aim of this work is to determine neoplasm frequency, relationship with the prescription pattern of DMTs, and influence of the patients’ baseline characteri...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosalía Gil-Bernal, Juan Luis González-Caballero, Raúl Espinosa-Rosso, Carmen Gómez-Gómez
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/9e0434f4136d47b6b5db10f717e47481
Tags: Add Tag
No Tags, Be the first to tag this record!